SCHEMBL28380657

SCHEMBL28380657

O=C(Nc1cccc(N2CCOCC2)c1N1CCOCC1)c1cccc(-c2cn[nH]c2)n1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 13/20 0.64
▸ ALDH1A1 P00352 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ CHEK1 O14757 1/20 0.48
▸ CYP1A2 P05177 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ IRAK1 P51617 1/20 0.46
▸ SCN9A Q15858 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28383182 0.97 IRAK4 (0.68) IRAK4ALDH1A1TSHRNPSR1CHEK1
SCHEMBL28379236 0.96 IRAK4 (0.69) IRAK4ALDH1A1TSHRNPSR1CHEK1
SCHEMBL20598195 0.85 IRAK4 (0.67) IRAK4ALDH1A1TSHRNPSR1CHEK1
SCHEMBL28383358 0.84 CHEK1 (0.69) IRAK4CHEK1
SCHEMBL20598097 0.83 IRAK4 (0.71) IRAK4CHEK1IRAK1SMN1; SMN2
SCHEMBL20598638 0.82 IRAK4 (0.72) IRAK4ALDH1A1TSHRNPSR1CHEK1
SCHEMBL20598190 0.82 IRAK4 (0.72) IRAK4CHEK1IRAK1SMN1; SMN2
SCHEMBL28382785 0.82 CHEK1 (0.66) IRAK4CHEK1
SCHEMBL20598608 0.82 IRAK4 (0.71) IRAK4NPSR1IRAK1SCN9A
SCHEMBL28383357 0.82 CHEK1 (0.65) IRAK4CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-A Kinase inhibitors and methods of making and using 里格尔药品股份有限公司 2020-04-17 — — CN claimed
CN-111032642-A Kinase inhibitors and methods of making and using 里格尔药品股份有限公司 2020-04-17 — — CN disclosed
Send feedback